Cancer Institute A national cancer institute
designated cancer center

Xiaoyuan (Shawn) Chen

Publication Details

  • (68)Ga-labeled NOTA-RGD-BBN peptide for dual integrin and GRPR-targeted tumor imaging.

    Liu Z, Niu G, Wang F, Chen X. Eur J Nucl Med Mol Imaging. 2009; 36 (9): 1483-94

    Radiolabeled Arg-Gly-Asp (RGD) and bombesin (BBN) peptide analogs have been extensively investigated for the imaging of tumor integrin alpha(v)beta(3) and gastrin-releasing peptide receptor (GRPR) expression, respectively. Recently, we designed and synthesized a RGD-BBN heterodimeric peptide from c(RGDyK) and BBN(7-14) through a glutamate linker. The goal of this study was to investigate the dual receptor-targeting property and tumor diagnostic value of RGD-BBN heterodimeric peptide labeled with generator-eluted (68)Ga (t(1/2) 68 min, beta(+) 89% and EC 11%), (68)Ga-NOTA-RGD-BBN.

    PubMedID: 19360404

Stanford Medicine Resources:

Footer Links: